oseltamivir lupin oseltamivir (as phosphate) 75 mg capsule blister pack
lupin australia pty limited - oseltamivir phosphate, quantity: 98.524 mg - capsule, hard - excipient ingredients: povidone; sodium stearylfumarate; pregelatinised maize starch; purified talc; croscarmellose sodium; ethanol absolute; titanium dioxide; purified water; iron oxide yellow; gelatin; iron oxide black - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.
oseltamivir lupin oseltamivir (as phosphate) 45 mg capsule blister pack
lupin australia pty limited - oseltamivir phosphate, quantity: 59.114 mg - capsule, hard - excipient ingredients: croscarmellose sodium; pregelatinised maize starch; sodium stearylfumarate; povidone; purified talc; ethanol absolute; titanium dioxide; purified water; gelatin; iron oxide black - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.
oseltamivir lupin oseltamivir (as phosphate) 30 mg capsule blister pack
lupin australia pty limited - oseltamivir phosphate, quantity: 39.41 mg - capsule, hard - excipient ingredients: sodium stearylfumarate; ethanol absolute; pregelatinised maize starch; croscarmellose sodium; povidone; purified talc; titanium dioxide; purified water; iron oxide yellow; gelatin - oseltamivir is indicated for the treatment of infections due to influenza a and b viruses in adults and children including full-term neonates. treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. vaccination is the preferred method of routine prophylaxis against infection with influenza virus.
gliclazide lupin mr gliclazide 60 mg modified release tablet blister pack
lupin australia pty limited - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: povidone; calcium hydrogen phosphate dihydrate; hypromellose; magnesium stearate - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
lupin flour 750micrograms/ml solution for skin prick test
inmunotek - lupin flour allergen extract - solution for skin-prick test
lupin-tiotropium capsule
lupin pharma canada limited - tiotropium (tiotropium bromide monohydrate) - capsule - 18mcg - tiotropium (tiotropium bromide monohydrate) 18mcg
ixime 100mg chewable tablet
lupin philippines, inc.; distributor: lupin philippines, inc. - cefixime (anhydrous) - chewable tablet - 100mg
cetil 500mg film-coated tablet
lupin philippines, inc.; distributor: lupin philippines, inc. - cefuroxime (as axetil) - film-coated tablet - 500mg
cetil 750mg powder for injection (im/iv)
lupin philippines, inc; distributor: lupin philippines, inc - cefuroxime (as sodium) - powder for injection (im/iv) - 750mg
lupiflox 30mg/ml (0.3% w/v) ophthalmic solution
lupin philippines, inc.; distributor: lupin philippines, inc. - gatifloxacin - ophthalmic solution - 30mg/ml (0.3% w/v)